News about Global Pharma

KBI Biopharma secures Swissmedic Regulatory Establishment License for Geneva facility

The license allows KBI to fully support clients in their next phases of growth and certifies KBI's manufacturing capabilities in a cGMP environment

Global Pharma | 26/12/2022 | By Sudeep Soparkar |  909

Florida-based Formulated Solutions to buy Merck & Co and Bayer manufacturing facility

The manufacturing facility is located in Cleveland, Tennessee

Global Pharma | 21/12/2022 | By Sudeep Soparkar |  1265

JB Pharma to acquire the entire Razel (Rosuvastatin) franchise for Rs. 314 crores

The acquisition marks JB Pharma’s entry into the ‘Statin’ segment which is the largest group in the cardiac therapy. Razel ranks among the top 10 brands in the Rosuvastatin molecule category in the country <br />

Global Pharma | 15/12/2022 | By Sudeep Soparkar |  654

Lupin appoints Spiro Gavaris as President of US generics biz

Gavaris will be responsible for the overall strategy, implementation and growth of Lupin’s US Generics business

Global Pharma | 09/12/2022 | By Sudeep Soparkar |  468

Akums enters into joint association with Leiutis and Biophore for therapeutics

The partnership leverages the strengths of each of the companies resulting in an innovation strategy creating a unique value proposition to doctors and patients in India

Global Pharma | 01/12/2022 | By Sudeep Soparkar |  1386

15th edition of CPHI & PMEC India showcases array of pharma machinery, equipment, ingredients and tech

The event witnessed 50,000 visitors from across the globe, more than 1,500 exhibitors and representation from over 80 countries

Global Pharma | 30/11/2022 | By Sudeep Soparkar |  576

Lupins' Brazilian arm buys nine brand rights from Bausch Health

Medqumica develops an extensive line of both solid and liquid medicines in Brazil

Global Pharma | 29/11/2022 | By Sudeep Soparkar |  907

Glenmark Pharma in agreement with Pfizer for Axitinib tabs, 1 mg and 5 mg

The Inlyta tablets, 1 mg and 5 mg market 2 achieved annual sales of approximately $644.5 million

Global Pharma | 22/11/2022 | By Sudeep Soparkar |  787

CPhI & P-MEC India expo to encourage cost-effective solutions

The shows will bring together over 1500 exhibitors showcasing 5000+ products across 100,000+ sq m of exhibition space

Global Pharma | 18/11/2022 | By Sudeep Soparkar |  1142

India pharma forecast record growth for 2023 ahead of CPHI & PMEC India

Scoring second only to the US in ‘growth potential’ and ‘overall competitiveness’ in the CPHI Annual Survey

Global Pharma | 16/11/2022 | By Sudeep Soparkar |  1147